Blog

Effective Oral Care Cuts Surgical Site Infections

Perioperative oral management significantly reduces surgical site infections (SSIs) and shortens hospital stays.

  • Oral care interventions lowered SSI risk by 36% in experimental studies (RR=0.64) and 51% in observational studies (OR=0.49).
  • Modest effects were noted in patients with cardiovascular disease (OR=0.72) and non-oncology patients (OR=0.66).

Implement tailored oral management plans to optimize preoperative care.

  • Protocols lacking chemical or mechanical cleaning showed no benefit (OR=0.76).
  • Patients experienced 1.88 fewer days in the hospital following effective oral care.

Review by Lin Y, Li E (…) Yu X et 3 al. in ANZ J Surg

© 2025 Royal Australasian College of Surgeons.

read the whole article in ANZ J Surg

open it in PubMed

Postoperative Analgesia: Emphasizing Oral Over IV

A study reveals a major disconnect in postoperative analgesia practices, highlighting a need for surgeons to consider oral routes for efficiency and cost savings.

  • Intravenous (IV) analgesia was used in 86% of non-opioid patients and 39% for opioids, while the oral route was utilized in only 1%.
  • Transitioning to oral analgesia can cut costs per patient from 822.3 RSD ($7.84) to 124.5 RSD ($1.19), achieving 85% savings.

This shift could enhance recovery times and reduce resource strain in surgical wards.

  • Among patients where oral administration was feasible, IV was still the choice for 86% of non-opioid and 38% of opioid cases.

Journal Article by Bojic S, Ladjevic N (…) Stamenkovic D et 7 al. in Front Med (Lausanne)

Copyright © 2025 Bojic, Ladjevic, Palibrk, Rancic, Bezmarevic, Meissner, Zaslansky, Stamer, Baumbach and Stamenkovic.

read the whole article in Front Med (Lausanne)

open it in PubMed

Guided Classification Improves Outcomes in Pancreatic Surgery

A new intraoperative classification system enhances pancreatic surgery for benign and low-grade tumors.

  • 122 patients underwent robotic resections with IPDECT; type I defects had a 10.6% overall complication rate including 8.5% for postoperative pancreatic fistula.
  • Type IV defects had longer operations (mean 127.6 min) yet only 5.9% complications.

Standardizing decision-making may enhance patient outcomes and preserve pancreatic function.

  • No tumor recurrence or metabolic issues were reported within 1 to 4 years post-surgery.

Journal Article by Huang Y, Hu H (…) He T et 2 al. in J Robot Surg

© 2025. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

read the whole article in J Robot Surg

open it in PubMed

NSAID Timing Impacts Early Leak Risk in Rectal Surgery

Early use of NSAIDs post-proctectomy increases the risk of early anastomotic leaks.

  • 8.7% overall rate of anastomotic leaks, with early NSAID use linked to higher rates (7.7% vs. 4.7%, p = 0.030).
  • Non-selective NSAIDs and multiple doses significantly heighten early leak risk (OR 1.717, p = 0.012; OR 1.687, p = 0.016).

Consider timing and drug selection when prescribing NSAIDs to minimize complications.

  • Increased perioperative bleeding noted with NSAID use (4.0% vs. 1.2%, p = 0.003).
  • Male patients and those without diverting stomas are at greater risk for early leaks related to NSAIDs.

Journal Article by Hu Z, Tan K (…) Tong W et 6 al. in Ann Surg Oncol

© 2025. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Single-port robotic esophagectomy shows promise

Single-port subcostal robotic esophagectomy is safe and feasible for esophageal cancer, with significant benefits for patient recovery.

  • R0 resection achieved in 100% of cases; mean lymph node yield was 30.
  • No intraoperative complications; mean total operative time was 324 minutes.
  • Postoperative complications included 8% pneumonia and 8% anastomotic leaks, all managed endoscopically.

This technique supports rapid recovery, low pain scores, and shorter hospital stays, making it a viable option for surgical practice.

Journal Article by Lozanovski VJ, Bellaio L (…) Grimminger PP et 6 al. in Surg Endosc

© 2025. The Author(s).

read the whole article in Surg Endosc

open it in PubMed

Staged Resection Outperforms Simultaneous Strategy for Liver Metastases

Staged resection is safer and offers better outcomes than simultaneous resection for patients with initially unresectable colorectal liver metastases.

  • Staged resection had lower overall complications (35.8% vs. 48.9%, p=0.014) and major complications (14.8% vs. 24.1%, p=0.027).
  • Staged resection significantly improved relapse-free survival (HR=0.780, p=0.030) and liver-specific survival (HR=0.737, p=0.011).

Adopting staged resection could enhance surgical results for these patients.

  • Multivariable analysis confirmed benefits in survival metrics for staged over simultaneous resection.

Journal Article by Chen Y, Zhu J (…) Xu J et 12 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Revolutionizing Diastasis Recti Treatment

Postpartum diastasis recti affects up to 60% of women, impacting recovery and quality of life.

  • AI-enhanced ultrasounds exceed traditional imaging with an accuracy score of 85.93%.
  • Laparoscopic “slim-mesh” repairs show recurrence rates under 10%, outperforming open surgery.

Implementing precision medicine could tailor interventions based on individual patient profiles.

  • Intelligent rehab systems can effectively reduce inter-rectus distance using real-time feedback.

Systematic Review by Huang M, Huang Z and Huang H in BMC Surg

© 2025. The Author(s).

read the whole article in BMC Surg

open it in PubMed

Early-Onset Colorectal Cancer: New Insights on Lymph Node Metastasis

Understanding lymph node metastasis in early-onset colorectal cancer is crucial for surgical decision-making and patient management.

  • Early-onset patients show more aggressive tumor features vs. late-onset: larger size, poorer differentiation, and higher lymphovascular invasion rates.
  • Key predictors for lymph node metastasis include elevated CA19-9, T3/T4 stage, nerve invasion, and lymphovascular invasion, with odds ratios over 2.4 for some factors.
  • High microsatellite instability is identified as a protective factor against metastasis.

These findings highlight the importance of age-specific assessment tools to tailor surgical approaches and improve outcomes for younger patients.

Journal Article by Sun X, Li R (…) Dong G et 3 al. in J Gastrointest Cancer

© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in J Gastrointest Cancer

open it in PubMed

Attrition Rates High in Neoadjuvant Therapy for Pancreatic Cancer

High attrition during neoadjuvant therapy (NAT) complicates surgical candidacy for localized pancreatic cancer, affecting patient outcomes.

  • Out of 427 patients receiving NAT, 57% did not proceed to pancreatectomy due to disease progression (21%) and persistent inoperability (22%).
  • Resectable patients had an attrition rate of 23%, compared to 44% for borderline resectable and 73% for locally advanced cases.

Understanding these attrition drivers is critical for surgical decision-making and patient selection, underscoring the need for proactive management strategies.

Journal Article by Dickey EM, Min L (…) Hester C et 8 al. in Ann Surg Oncol

© 2025. The Author(s).

read the whole article in Ann Surg Oncol

open it in PubMed

Predictors of Successful Pelvic Exenteration in Rectal Cancer

Pelvic exenteration for locally recurrent rectal cancer can achieve high rates of R0 resection, with important predictors identified for optimizing outcomes.

  • R0 resection was accomplished in 81% of patients (244/300).
  • Neoadjuvant radiotherapy significantly improved R0 resection rates (OR=2.773).
  • Age influences overall survival, with a hazard ratio of 1.022 per year increase.

Use these insights to refine patient selection and enhance preoperative counseling, aiming for better shared decision-making.

Journal Article by Brown KGM, Ng KS (…) Steffens D et 5 al. in Eur J Surg Oncol

Copyright © 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

read the whole article in Eur J Surg Oncol

open it in PubMed